Amedisys Sees Unusually Large Options Volume (NASDAQ:AMED)

Amedisys, Inc. (NASDAQ:AMED - Get Free Report) was the target of some unusual options trading on Friday. Traders bought 3,269 put options on the stock. This represents an increase of approximately 136% compared to the average volume of 1,385 put options.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the business. National Bank of Canada FI lifted its position in shares of Amedisys by 119.0% during the third quarter. National Bank of Canada FI now owns 55,592 shares of the health services provider's stock worth $5,365,000 after acquiring an additional 30,213 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Amedisys by 4.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 514,166 shares of the health services provider's stock valued at $47,202,000 after purchasing an additional 19,660 shares during the period. Geode Capital Management LLC lifted its holdings in Amedisys by 1.3% during the 3rd quarter. Geode Capital Management LLC now owns 567,105 shares of the health services provider's stock worth $54,746,000 after purchasing an additional 7,071 shares in the last quarter. Quarry LP bought a new position in Amedisys in the 3rd quarter worth about $2,569,000. Finally, Charles Schwab Investment Management Inc. grew its holdings in Amedisys by 2.7% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 346,082 shares of the health services provider's stock valued at $33,400,000 after buying an additional 9,004 shares in the last quarter. 94.36% of the stock is owned by institutional investors.

Amedisys Stock Performance

Shares of NASDAQ AMED traded up $4.01 during trading on Friday, reaching $89.96. 2,013,218 shares of the stock traded hands, compared to its average volume of 389,869. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. The stock has a market capitalization of $2.95 billion, a P/E ratio of 35.70, a price-to-earnings-growth ratio of 1.84 and a beta of 0.73. Amedisys has a 52-week low of $82.15 and a 52-week high of $98.95. The company has a 50-day moving average of $90.45 and a 200-day moving average of $94.43.

Amedisys (NASDAQ:AMED - Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.19). The business had revenue of $587.67 million for the quarter, compared to analysts' expectations of $586.75 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. Amedisys's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period last year, the company earned $0.98 earnings per share. Analysts forecast that Amedisys will post 4.45 EPS for the current fiscal year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.